General Forum, page-654

CDX share price after FDA approval might depend on 5 factors:

1) How well it’s promoted. Good promotion, e.g. mentioning launch partners, can attract buyers.
2) Regal’s response. They could sell the news or they could hold.
3) World stock market sentiment. If the whole market is going bad, then people usually sell the news regardless of the company’s quality.
4) US listing. If it gets good institutional support and captures the imagination in America, the share price could go bonkers.
5) Pumpers. I’ve seen some amazing stock runs that have obviously been caused by some (maybe offshore) pumping group, and CDX would be a great candidate due to low liquidity and a great story.

My guess is that the price will jump to around 45c, and then Regal will sell into that, or it will get pumped to around 60c and then Regal will sell into that. Then US listing will lead to a huge pump sooner or later. I remember Craig said something like, “US listing is not as simple as starting with a price like 15 cents.” Presumably, he was thinking in pre-consolidation terms, so he meant $1.50. Obviously, they want the US listing to start at a high price because it reduces dilution. So I’m sure management will be working for a high priced US listing.

Note: Resistance levels in the last 2 years have been: 44c, 60c, 72c, 77c, and $1. It was really slammed down hard from 60c recently. And for the sake of comparison, NUH doubled after FDA news and then got dumped presumably due to funding concerns even though they have a HP product due to be released within a month.